Sprachsituation einzelner Gebiete Mathematik Wissenschaft Sozialwissenschaft Unternehmen Ingenieurwissenschaft Geisteswissenschaft Geschichte
  1. Wissenschaft
  2. Biologie
  3. Pharmakologie
Rote-Hand-Brief zu Vistide® (Cidofovir)
Rote-Hand-Brief zu Vistide® (Cidofovir)
Rote-Hand-Brief zu Velcade® (Bortezomib)
Rote-Hand-Brief zu Velcade® (Bortezomib)
Rote-Hand-Brief zu Vectibix® (Panitumumab)
Rote-Hand-Brief zu Vectibix® (Panitumumab)
Rote-Hand-Brief zu Vectibix
Rote-Hand-Brief zu Vectibix
Rote-Hand-Brief zu Tredaptive® (Nikotinsäure/Laropiprant)
Rote-Hand-Brief zu Tredaptive® (Nikotinsäure/Laropiprant)
Rote-Hand-Brief zu Torisel® (Temsirolimus)
Rote-Hand-Brief zu Torisel® (Temsirolimus)
Rote-Hand-Brief zu Stelara® (Ustekinumab)
Rote-Hand-Brief zu Stelara® (Ustekinumab)
Rote-Hand-Brief zu Sprycel® (Dasatinib)
Rote-Hand-Brief zu Sprycel® (Dasatinib)
Rote-Hand-Brief zu Protelos® (Strontiumranelat)
Rote-Hand-Brief zu Protelos® (Strontiumranelat)
Rote-Hand-Brief zu Perfalgan® (Paracetamol i.v.)
Rote-Hand-Brief zu Perfalgan® (Paracetamol i.v.)
Rote-Hand-Brief zu Pegasys® (pegyliertes Interferon alfa-2a)
Rote-Hand-Brief zu Pegasys® (pegyliertes Interferon alfa-2a)
Rote-Hand-Brief zu Moxifloxacin-Tabletten
Rote-Hand-Brief zu Moxifloxacin-Tabletten
Rote-Hand-Brief zu Mimpara - Arzneimittelkommission der
Rote-Hand-Brief zu Mimpara - Arzneimittelkommission der
Rote-Hand-Brief zu Lariam® (Mefloquin)
Rote-Hand-Brief zu Lariam® (Mefloquin)
Rote-Hand-Brief zu InductOs® (Dibotermin alfa): Möglicher
Rote-Hand-Brief zu InductOs® (Dibotermin alfa): Möglicher
Rote-Hand-Brief zu Imnovid® (Pomalidomid)
Rote-Hand-Brief zu Imnovid® (Pomalidomid)
Rote-Hand-Brief zu Herceptin
Rote-Hand-Brief zu Herceptin
Rote-Hand-Brief zu Fumaderm® initial / Fumaderm
Rote-Hand-Brief zu Fumaderm® initial / Fumaderm
Rote-Hand-Brief zu Fluorescein Alcon® 10
Rote-Hand-Brief zu Fluorescein Alcon® 10
Rote-Hand-Brief zu Doribax® (Doripenem)
Rote-Hand-Brief zu Doribax® (Doripenem)
Rote-Hand-Brief zu Domperidon vom 20.08.2014
Rote-Hand-Brief zu Domperidon vom 20.08.2014